Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration

Prashanti Patil, Qing Dong, Dong Wang, Jianhui Chang, Christopher Wiley, Marco Demaria, Joon Lee, James Kang, Laura J. Niedernhofer, Paul D. Robbins, Gwendolyn Sowa, Judith Campisi, Daohong Zhou, Nam Vo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rationale: Age-related changes in the intervertebral discs are the predominant contributors to back pain, a common physical and functional impairment experienced by older persons. Cellular senescence, a process wherein cells undergo growth arrest and chronically secrete numerous inflammatory molecules and proteases, has been reported to cause decline in the health and function of multiple tissues with age. Although senescent cells have been reported to increase in intervertebral degeneration (IDD), it is not known whether they are causative in age-related IDD. Objective: The study aimed to elucidate whether a causal relationship exists between cellular senescence and age-related IDD. Methods and Results: To examine the impact of senescent cells on age-associated IDD, we used p16-3MR transgenic mice, which enables the selective removal of p16Ink4a-positive senescent cells by the drug ganciclovir. Disc cellularity, aggrecan content and fragmentation alongside expression of inflammatory cytokine (IL-6) and matrix proteases (ADAMTS4 and MMP13) in discs of p16-3MR mice treated with GCV and untreated controls were assessed. In aged mice, reducing the per cent of senescent cells decreased disc aggrecan proteolytic degradation and increased overall proteoglycan matrix content along with improved histological disc features. Additionally, reduction of senescent cells lowered the levels of MMP13, which is purported to promote disc degenerative changes during aging. Conclusions: The findings of this study suggest that systemic reduction in the number of senescent cells ameliorates multiple age-associated changes within the disc tissue. Cellular senescence could therefore serve as a therapeutic target to restore the health of disc tissue that deteriorates with age.

Original languageEnglish (US)
Article numbere12927
JournalAging cell
Volume18
Issue number3
DOIs
StatePublished - Jun 2019

Fingerprint

Intervertebral Disc Degeneration
Cell Aging
Aggrecans
Peptide Hydrolases
Ganciclovir
Intervertebral Disc
Health
Proteoglycans
Back Pain
Transgenic Mice
Interleukin-6
Cell Count
Cytokines
Growth
Pharmaceutical Preparations

Keywords

  • aggrecanolysis
  • aging
  • cellular senescence
  • intervertebral disc
  • p16
  • proteoglycan

PubMed: MeSH publication types

  • Journal Article

Cite this

Patil, P., Dong, Q., Wang, D., Chang, J., Wiley, C., Demaria, M., ... Vo, N. (2019). Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration. Aging cell, 18(3), [e12927]. https://doi.org/10.1111/acel.12927

Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration. / Patil, Prashanti; Dong, Qing; Wang, Dong; Chang, Jianhui; Wiley, Christopher; Demaria, Marco; Lee, Joon; Kang, James; Niedernhofer, Laura J.; Robbins, Paul D.; Sowa, Gwendolyn; Campisi, Judith; Zhou, Daohong; Vo, Nam.

In: Aging cell, Vol. 18, No. 3, e12927, 06.2019.

Research output: Contribution to journalArticle

Patil, P, Dong, Q, Wang, D, Chang, J, Wiley, C, Demaria, M, Lee, J, Kang, J, Niedernhofer, LJ, Robbins, PD, Sowa, G, Campisi, J, Zhou, D & Vo, N 2019, 'Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration', Aging cell, vol. 18, no. 3, e12927. https://doi.org/10.1111/acel.12927
Patil, Prashanti ; Dong, Qing ; Wang, Dong ; Chang, Jianhui ; Wiley, Christopher ; Demaria, Marco ; Lee, Joon ; Kang, James ; Niedernhofer, Laura J. ; Robbins, Paul D. ; Sowa, Gwendolyn ; Campisi, Judith ; Zhou, Daohong ; Vo, Nam. / Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration. In: Aging cell. 2019 ; Vol. 18, No. 3.
@article{462580fa76a449a3a78edc7046060801,
title = "Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration",
abstract = "Rationale: Age-related changes in the intervertebral discs are the predominant contributors to back pain, a common physical and functional impairment experienced by older persons. Cellular senescence, a process wherein cells undergo growth arrest and chronically secrete numerous inflammatory molecules and proteases, has been reported to cause decline in the health and function of multiple tissues with age. Although senescent cells have been reported to increase in intervertebral degeneration (IDD), it is not known whether they are causative in age-related IDD. Objective: The study aimed to elucidate whether a causal relationship exists between cellular senescence and age-related IDD. Methods and Results: To examine the impact of senescent cells on age-associated IDD, we used p16-3MR transgenic mice, which enables the selective removal of p16Ink4a-positive senescent cells by the drug ganciclovir. Disc cellularity, aggrecan content and fragmentation alongside expression of inflammatory cytokine (IL-6) and matrix proteases (ADAMTS4 and MMP13) in discs of p16-3MR mice treated with GCV and untreated controls were assessed. In aged mice, reducing the per cent of senescent cells decreased disc aggrecan proteolytic degradation and increased overall proteoglycan matrix content along with improved histological disc features. Additionally, reduction of senescent cells lowered the levels of MMP13, which is purported to promote disc degenerative changes during aging. Conclusions: The findings of this study suggest that systemic reduction in the number of senescent cells ameliorates multiple age-associated changes within the disc tissue. Cellular senescence could therefore serve as a therapeutic target to restore the health of disc tissue that deteriorates with age.",
keywords = "aggrecanolysis, aging, cellular senescence, intervertebral disc, p16, proteoglycan",
author = "Prashanti Patil and Qing Dong and Dong Wang and Jianhui Chang and Christopher Wiley and Marco Demaria and Joon Lee and James Kang and Niedernhofer, {Laura J.} and Robbins, {Paul D.} and Gwendolyn Sowa and Judith Campisi and Daohong Zhou and Nam Vo",
year = "2019",
month = "6",
doi = "10.1111/acel.12927",
language = "English (US)",
volume = "18",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration

AU - Patil, Prashanti

AU - Dong, Qing

AU - Wang, Dong

AU - Chang, Jianhui

AU - Wiley, Christopher

AU - Demaria, Marco

AU - Lee, Joon

AU - Kang, James

AU - Niedernhofer, Laura J.

AU - Robbins, Paul D.

AU - Sowa, Gwendolyn

AU - Campisi, Judith

AU - Zhou, Daohong

AU - Vo, Nam

PY - 2019/6

Y1 - 2019/6

N2 - Rationale: Age-related changes in the intervertebral discs are the predominant contributors to back pain, a common physical and functional impairment experienced by older persons. Cellular senescence, a process wherein cells undergo growth arrest and chronically secrete numerous inflammatory molecules and proteases, has been reported to cause decline in the health and function of multiple tissues with age. Although senescent cells have been reported to increase in intervertebral degeneration (IDD), it is not known whether they are causative in age-related IDD. Objective: The study aimed to elucidate whether a causal relationship exists between cellular senescence and age-related IDD. Methods and Results: To examine the impact of senescent cells on age-associated IDD, we used p16-3MR transgenic mice, which enables the selective removal of p16Ink4a-positive senescent cells by the drug ganciclovir. Disc cellularity, aggrecan content and fragmentation alongside expression of inflammatory cytokine (IL-6) and matrix proteases (ADAMTS4 and MMP13) in discs of p16-3MR mice treated with GCV and untreated controls were assessed. In aged mice, reducing the per cent of senescent cells decreased disc aggrecan proteolytic degradation and increased overall proteoglycan matrix content along with improved histological disc features. Additionally, reduction of senescent cells lowered the levels of MMP13, which is purported to promote disc degenerative changes during aging. Conclusions: The findings of this study suggest that systemic reduction in the number of senescent cells ameliorates multiple age-associated changes within the disc tissue. Cellular senescence could therefore serve as a therapeutic target to restore the health of disc tissue that deteriorates with age.

AB - Rationale: Age-related changes in the intervertebral discs are the predominant contributors to back pain, a common physical and functional impairment experienced by older persons. Cellular senescence, a process wherein cells undergo growth arrest and chronically secrete numerous inflammatory molecules and proteases, has been reported to cause decline in the health and function of multiple tissues with age. Although senescent cells have been reported to increase in intervertebral degeneration (IDD), it is not known whether they are causative in age-related IDD. Objective: The study aimed to elucidate whether a causal relationship exists between cellular senescence and age-related IDD. Methods and Results: To examine the impact of senescent cells on age-associated IDD, we used p16-3MR transgenic mice, which enables the selective removal of p16Ink4a-positive senescent cells by the drug ganciclovir. Disc cellularity, aggrecan content and fragmentation alongside expression of inflammatory cytokine (IL-6) and matrix proteases (ADAMTS4 and MMP13) in discs of p16-3MR mice treated with GCV and untreated controls were assessed. In aged mice, reducing the per cent of senescent cells decreased disc aggrecan proteolytic degradation and increased overall proteoglycan matrix content along with improved histological disc features. Additionally, reduction of senescent cells lowered the levels of MMP13, which is purported to promote disc degenerative changes during aging. Conclusions: The findings of this study suggest that systemic reduction in the number of senescent cells ameliorates multiple age-associated changes within the disc tissue. Cellular senescence could therefore serve as a therapeutic target to restore the health of disc tissue that deteriorates with age.

KW - aggrecanolysis

KW - aging

KW - cellular senescence

KW - intervertebral disc

KW - p16

KW - proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=85065879708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065879708&partnerID=8YFLogxK

U2 - 10.1111/acel.12927

DO - 10.1111/acel.12927

M3 - Article

C2 - 30900385

AN - SCOPUS:85065879708

VL - 18

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 3

M1 - e12927

ER -